WO2000029411A1 - An improved process for the preparation of 7-azaindolyl-3-carboxylic acid - Google Patents
An improved process for the preparation of 7-azaindolyl-3-carboxylic acid Download PDFInfo
- Publication number
- WO2000029411A1 WO2000029411A1 PCT/IB1999/001834 IB9901834W WO0029411A1 WO 2000029411 A1 WO2000029411 A1 WO 2000029411A1 IB 9901834 W IB9901834 W IB 9901834W WO 0029411 A1 WO0029411 A1 WO 0029411A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tert
- azaindole
- butyl
- give
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Definitions
- the object of the present invention relates to an improved process for the preparation of 7-azaindolyl- 3-carboxylic acid, starting compound for the synthesis of compounds having relevant pharmacological interest. More particularly 7-azaindolyl-3-carboxylic acid or lH-pyrrole[2,3-b]pyridin-3-carboxylic acid of structure formula:
- 7-azaindolyl-3-carboxylic acid has been prepared from 7-azaindole by means of a method consisting in a Friedel-Cra ts acylation with trichloroacetyl chloride and a molar excess of A1C1 3 followed by a treatment of the so obtained 7- azaindolyl-3-trichloroacetyl with a suitable base to remove chloroform and provide the desired 7- azaindolyl-3-carboxylic acid (I) .
- the starting compound of such a process is a compound hard to find on the market and, when available, it is very expensive: consequently the market price of the 7-azaindolyl-3-carboxylic acid, due both to the difficulty in finding the starting compound and to the complexity of the synthesis in obtaining it, is so high that a possible production of the active principles described in USP n°5,750,536 would be too expensive .
- the process of the present invention is essentially based on the method described in both Helv.Chimica Acta 33,273,1950 and J.Chem.Soc. Perk 1,1910,1975; then removal of the tert.butyl radical from the new intermediate 1- tert .butyl-3-cyano-7-azaindole (IV) is performed with an alternative technology which is certainly advantageous in respect to the one followed to the present time.
- succinonitrile (VIII) and a suitable alkyl formate are condensed in the presence of a base to form a salt of 2- hydroxymethylenebutyrronitrile (VII) which is not separated from the reaction mixture but made to react with an excess of ter .butyla ine, giving the corresponding enaminonitrile.
- VI from which, by internal condensation, in. the presence of a base, the corresponding l-tert.butyl-2-amino-4-cyanopyrrole (V) is obtained.
- l-tert.Butyl-2-amino-4-cyanopyrrole (V) 5 is then reacted with a alondialdehyde acetal in the presence of a suitable catalyst, such as p.toluensulphonic acid, to provide l-tert.butyl-3- cyano-7-azaindole (IV) which is then treated in a warm ambience with at least three molar equivalents of a Lewis acid to remove the tert.
- a suitable catalyst such as p.toluensulphonic acid
- the condensation reaction (a) is preferably performed in an inert organic solvent and the base is represented by a metal alkaline salt of an aliphatic alcohol, more preferably a sodium or potassium salt of an aliphatic alcohol, such as, for example, sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert.butoxide, sodium tert.butoxide; sodium methoxide and potassium tert.butoxide being the preferred ones.
- Suitable solvents are, for example, aliphatic alcohols such as ethanol, ethanol, 2- propanol, sec.butanol and tert.butanol as well as aromatic solvents such as benzene and toluene.
- the cyclization reaction (c) is preferably carried out in a warm ambience, in the presence of sodium or potassium hydroxide in a solvent consisting of aliphatic alcohol, preferably ethanol.
- the reaction (d) for obtaining the azaindolyl ring is carried out under reflux in an aromatic solvent such as toluene.
- the reaction (e) for removing the tert.butyl radical is performed reacting 1-tert .butyl-3-cyano-7-azaindole (IV) in a high boiling organic solvent with at least three molar equivalents of a Lewis acid selected in the group consisting of aluminium chloride, boron chloride and boron bromide, preferably aluminium chloride.
- a Lewis acid selected in the group consisting of aluminium chloride, boron chloride and boron bromide, preferably aluminium chloride.
- preferred high boiling organic solvent is represented by an aromatic hydrocarbon, which is ecologically compatible, such as, for example, toluene, xylenes and chlorobenzene .
- the dichloroaluminate intermediate (III) is suitably protonated (f) to give the cyano derivative (II) then hydrolyzed (g) at 70°C with an aqueous solution of a mineral acid to provide, with very high yields, the desired 7-azaindolyl-3-carboxylic acid (I) .
- the proton donor may be represented by an aliphatic alcohol containing 1-4 carbon atoms selected in the group consisting of methanol, ethanol, isopropanol and tert .butanol: methanol being the preferred one.
- the hydrochloric acid concentration as well as the reaction temperature are binding items in order to avoid a possible simultaneous decarboxylation of the 7-azaindolyl-3-carboxylic acid to 7-azaindole (IX) .
- a sample crystallized from isopropyl ether melts at 112-113°C.
- the reaction mixture is heated to reflux to give a homogeneous solution and it is kept under reflux temperature for 16 hours. Then it is cooled to room temperature and, while keeping the temperature unchanged, 40 ml of methanol are added dropwise over a period of 15 minutes. It is maintained under stirring for one hour till complete dissolution of the solid materials eventually formed and separated, during the reaction.
- 600mL 2N hydrochloric acid are added dropwise. The phases are separated: the organic phase is discharged and the aqueous phase, separated by filtration from the insoluble residues, is treated with 32% NaOH, adjusted to pH 2.2 to give 15.35g 3-cyano-7-azaindole as a crystalline precipitate. Yield 89%.
- a suspension of 15g 3-cyano-7-azaindole in 150mL 32% hydrochloric acid and 150mL water is heated to 70°C to give a homogeneous solution which is kept at this temperature for 20 hours.
- the solution is decolorized at 70°C for about 2 hours with 0.4g charcoal, then filtered in a warm ambience on a celite panel.
- the filtrate is cooled to about 8-10°C and 7-azaindolyl-3- carboxylic acid starts precipitation, which is complete after addition of about 120mL 32% NaOH, an amount sufficient to keep the pH of the mixture at about 2.5.
- Stirring is maintained at room temperature for 2 hours, the precipitate is filtered and washed with water till disappearance of chloride ions in the filtrate.
- the precipitate is dried to give 15.45g 7- azaindolyl-3-carboxylic acid as a white solid.
- a sample crystallized from 2N EtOH/HCl 4:1 melts at 246°C. Yield 9
- a solution of 5.1g (0.026 moles) 1-tert.butyl-3-cyano- 7-azaindole (IV) in 50mL 37% hydrochloric acid is heated under reflux for 24 hours. After cooling the solution to 70°C, a further 50mL 37% of hydrochloric acid are added and reflux is maintained for further 24 hours .
- the mixture is cooled to room temperature and diluted with lOOmL water.
- the solution is decolorized by adding O.lg charcoal and the insoluble is filtered on a celite panel. The filtrate is adjusted to pH 2 with a 32% sodium hydroxide solution, then transferred into a separating funnel and washed with 50mL methylene chloride.
- the aqueous phase containing 7- azaindole is adjusted to pH 7.5 with a 32% sodium hydroxide solution and extracted twice with 50mL methylene chloride each.
- the organic phases collected together are made anhydrous on sodium sulphate, evaporated under vacuum to give 2.35g 7-azaindole as a white solid melting at 105-106°C. Yield 75%.
- Example 9 7-Azaindole (IX) A solution of lg (0.07 moles) 3-cyano-7-azaindole (II) in lOmL 37% hydrochloric acid is heated under reflux for 24 hours. After cooling the solution to 70°C, a further lOmL 37% of hydrochloric acid are added and reflux is maintained for a further 24 hours. The solution is cooled to room temperature and, after addition of 20mL water, it is adjusted to pH 2.5 with a 32% sodium hydroxide solution.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0104278A HUP0104278A3 (en) | 1998-11-17 | 1999-11-12 | Novel process for the preparation of 7-azaindolyl-3-carboxylic acid and 7-azaindol and their intermediates |
JP2000582398A JP2002530282A (en) | 1998-11-17 | 1999-11-12 | Process for producing improved 7-azaindolyl-3-carboxylic acid |
AU64845/99A AU6484599A (en) | 1998-11-17 | 1999-11-12 | An improved process for the preparation of 7-azaindolyl-3-carboxylic acid |
EP99952758A EP1149098A1 (en) | 1998-11-17 | 1999-11-12 | An improved process for the preparation of 7-azaindolyl-3-carboxylic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002480A IT1303759B1 (en) | 1998-11-17 | 1998-11-17 | IMPROVED PROCEDURE FOR THE PREPARATION OF 7-AZAINDOLYL-3-CARBOXYLIC ACID. |
ITMI98A002480 | 1998-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000029411A1 true WO2000029411A1 (en) | 2000-05-25 |
Family
ID=11381069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/001834 WO2000029411A1 (en) | 1998-11-17 | 1999-11-12 | An improved process for the preparation of 7-azaindolyl-3-carboxylic acid |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1149098A1 (en) |
JP (1) | JP2002530282A (en) |
AU (1) | AU6484599A (en) |
HU (1) | HUP0104278A3 (en) |
IT (1) | IT1303759B1 (en) |
WO (1) | WO2000029411A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8865735B2 (en) | 2011-02-21 | 2014-10-21 | Hoffman-La Roche Inc. | Solid forms of a pharmaceutically active substance |
US9096593B2 (en) | 2009-11-06 | 2015-08-04 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
US9169250B2 (en) | 2006-11-22 | 2015-10-27 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US9447089B2 (en) | 2009-04-03 | 2016-09-20 | Plexxikon Inc. | Compositions and uses thereof |
US9469640B2 (en) | 2007-07-17 | 2016-10-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
-
1998
- 1998-11-17 IT IT1998MI002480A patent/IT1303759B1/en active
-
1999
- 1999-11-12 WO PCT/IB1999/001834 patent/WO2000029411A1/en not_active Application Discontinuation
- 1999-11-12 AU AU64845/99A patent/AU6484599A/en not_active Abandoned
- 1999-11-12 EP EP99952758A patent/EP1149098A1/en not_active Withdrawn
- 1999-11-12 HU HU0104278A patent/HUP0104278A3/en unknown
- 1999-11-12 JP JP2000582398A patent/JP2002530282A/en active Pending
Non-Patent Citations (1)
Title |
---|
A. BRODRICK ET AL.: "1H-Pyrrolo[2,3-b]pyridines. Part III. A novel synthetic route from 1-substituted 2-aminopyrroles", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1., 1975, CHEMICAL SOCIETY. LETCHWORTH., GB, pages 1010 - 13, XP002129794, ISSN: 0300-922X * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9487515B2 (en) | 2006-11-22 | 2016-11-08 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US9169250B2 (en) | 2006-11-22 | 2015-10-27 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US9469640B2 (en) | 2007-07-17 | 2016-10-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US10426760B2 (en) | 2007-07-17 | 2019-10-01 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9844539B2 (en) | 2007-07-17 | 2017-12-19 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9663517B2 (en) | 2009-04-03 | 2017-05-30 | Plexxikon Inc. | Compositions and uses thereof |
US9447089B2 (en) | 2009-04-03 | 2016-09-20 | Plexxikon Inc. | Compositions and uses thereof |
US9096593B2 (en) | 2009-11-06 | 2015-08-04 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US11337976B2 (en) | 2011-02-07 | 2022-05-24 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US12076322B2 (en) | 2011-02-07 | 2024-09-03 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US8865735B2 (en) | 2011-02-21 | 2014-10-21 | Hoffman-La Roche Inc. | Solid forms of a pharmaceutically active substance |
US9695169B2 (en) | 2012-05-31 | 2017-07-04 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
Also Published As
Publication number | Publication date |
---|---|
ITMI982480A1 (en) | 2000-05-17 |
IT1303759B1 (en) | 2001-02-23 |
EP1149098A1 (en) | 2001-10-31 |
HUP0104278A2 (en) | 2002-04-29 |
HUP0104278A3 (en) | 2002-06-28 |
JP2002530282A (en) | 2002-09-17 |
AU6484599A (en) | 2000-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100790766B1 (en) | Crystalline forms of Atorvastatin, a process for the preparation thereof and a pharmaceutical composition comprising the same | |
MXPA03003459A (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof. | |
WO2000029411A1 (en) | An improved process for the preparation of 7-azaindolyl-3-carboxylic acid | |
HU226957B1 (en) | Process for preparing tyrosine derivatives as fibrinogen receptor antagonists | |
JP2005514459A (en) | Method for producing phenserine and its analogs | |
US20030032800A1 (en) | Dibenzo(b,f)azepine derivatives and their preparation | |
US6187926B1 (en) | Process for producing quinolone derivatives | |
US4843166A (en) | 4-benzyloxy-3-pyrrolin-2-on-1-yl acetamide production | |
HU200446B (en) | Process for production of 1-alkyl-5-nitro-imidasoles | |
CA2373193A1 (en) | Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid additionsalts thereof | |
US20060178519A1 (en) | Process for preparing tegaserod | |
JP3205634B2 (en) | Method for producing 2-chloro-5-alkylaminomethyl-pyridines | |
US4958029A (en) | Process for the production of isoindoline derivatives, novel intermediates and process for their production | |
WO2007052296A2 (en) | A process of preparing amorphous atorvastatin calcium | |
JPH0742269B2 (en) | 4-Alkoxy-3-pyrrolin-2-one-1-yl-acetic acid alkyl ester and process for producing the same | |
EP0431305B1 (en) | Process for the preparation of molluscicidal 2,4,5-tribromopyrrole-3-carbonitrile compounds | |
HU203540B (en) | Process for producing 1-propargyl-2,4-dioxo-imidazolidine | |
JP3031279B2 (en) | Method for producing 2-alkoxy-6- (trifluoromethyl) pyrimidin-4-ol | |
JP2001510830A (en) | Method for preparing 1,3-diaza-spiro (4,4) non-1-en-4-one derivative and 1-cyano-1-acylaminocyclopentane intermediate | |
EP0066440B1 (en) | Chemical process | |
AU744361B2 (en) | Method for producing a 1-(3-cyclopentenyloxy- 4-alkoxyphenyl)-4- oxocyclohexanecarbonitrile | |
US5932767A (en) | Process for preparing dibenzocycloheptene compounds | |
EP0245913B1 (en) | Process for preparing 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid | |
NZ236080A (en) | 2(s)-stereoisomeric form of 2-aminomethyl-3- (1-carboxycyclopentyl)propanoic acid derivatives, intermediates thereto and processes for the preparation thereof | |
SK104698A3 (en) | Method for the preparation of 1-pyruvyl-l-proline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 1999 64845 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999952758 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 582398 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999952758 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999952758 Country of ref document: EP |